Role of adropin in arterial stiffening associated with obesity and type 2 diabetes.
Jaume Padilla,H. Rocha,S. Fujie,Yoskaly Lazo-Fernandez,Edgar Betancourt-Cortes,Neil J. McMillan,R. Rector,Camila Manrique-Acevedo,E. Parks,A. Butler,Subhashish Banerjee,L. Martinez‐Lemus,Mariana Morales-Quinones,Francisco I. Ramirez-Perez,Francisco J. Cabral-Amador,Neekun Sharma,T. Jurrissen,H. Sacks,R. Pettit-Mee,J. Ibdah,R. Soares
DOI: https://doi.org/10.1152/ajpheart.00385.2022
2022-09-09
Abstract:Adropin is a peptide largely secreted by the liver and known to regulate energy homeostasis; however, it also exerts cardiovascular effects. Herein, we tested the hypothesis that low circulating levels of adropin in obesity and type 2 diabetes (T2D) contribute to arterial stiffening. In support of this hypothesis, we report that obesity and T2D is associated with reduced levels of adropin (in liver and plasma) and increased arterial stiffness in mice and humans. Establishing causation, we show that mesenteric arteries from adropin knockout mice are also stiffer, relative to arteries from wild-type counterparts, thus recapitulating the stiffening phenotype observed in T2D db/db mice. Given the above, we performed a set of follow-up experiments, in which we found that: 1) exposure of endothelial cells or isolated mesenteric arteries from db/db mice to adropin reduces filamentous actin (F-actin) stress fibers and stiffness; 2) adropin-induced reduction of F-actin and stiffness in endothelial cells and db/db mesenteric arteries is abrogated by inhibition of nitric oxide (NO) synthase; and 3) stimulation of smooth muscle cells or db/db mesenteric arteries with a NO mimetic reduces stiffness. Last, we demonstrated that in vivo treatment of db/db mice with adropin for four weeks reduces stiffness in mesenteric arteries. Collectively, these findings indicate that adropin can regulate arterial stiffness, likely via endothelial-derived NO, and thus support the notion that "hypoadropinemia" should be considered as a putative target for the prevention and treatment of arterial stiffening in obesity and T2D.
Medicine,Biology